Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Mangalam Drugs and Organics Ltd (MADR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
102.90 +1.05    +1.03%
05:59:02 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE584F01014 
S/N:  MANGALAM
  • Volume: 21,630
  • Bid/Ask: 102.30 / 102.90
  • Day's Range: 101.80 - 103.00
Mangalam Drugs Organics 102.90 +1.05 +1.03%

MADR Recent Sentiments

 
This page contains information on users’ sentiments for the Mangalam Drugs and Organics Ltd stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 20, 2024 Shaikh Abdul Kaffar   123.50 Mar 15, 2024 @ 100.85 -18.34%
Oct 06, 2023 Rajesh Katarapu   102.45 Oct 06, 2023 @ 102.45 0.00%
Oct 19, 2021 Amit Sorte   144.00 Nov 12, 2021 @ 138.05 +4.13%
Oct 19, 2021 Amit Sorte   144.00 Nov 12, 2021 @ 138.05 +4.13%
Aug 29, 2021 Remesh Marangad   136.00 Aug 29, 2021 @ 136.00 0.00%
Aug 13, 2021 Rajesh Rajendran   161.05 Sep 03, 2021 @ 145.00 -9.97%
Aug 10, 2021 Paresh kotadiya   154.90 Sep 03, 2021 @ 145.00 -6.39%
Jul 28, 2021 sanweg kole   184.10 Aug 20, 2021 @ 145.50 -20.97%
Jun 21, 2021 arman aateef   146.60 Jul 16, 2021 @ 165.80 +13.10%
Jun 14, 2021 kalpana singhvi   130.95 Jul 09, 2021 @ 170.35 +30.09%
Jun 10, 2021 Ramanathan Gopalakris   131.30 Jul 02, 2021 @ 150.00 +14.24%
May 21, 2021 Ravi Dhetarwal   137.45 Jun 11, 2021 @ 131.45 -4.37%
Apr 01, 2021 Sudheendra Chandan   109.00 Apr 01, 2021 @ 109.00 0.00%
Feb 26, 2021 Raj Dipake   126.40 Mar 19, 2021 @ 109.70 -13.21%
Feb 25, 2021 vasireddy prasad   119.40 Mar 19, 2021 @ 109.70 -8.12%
Feb 25, 2021 Rahil Mehta   119.40 Mar 19, 2021 @ 109.70 -8.12%
Dec 01, 2020 Devil joker   149.10 Dec 25, 2020 @ 133.20 +10.66%
Oct 23, 2020 Alpesh Sadrani   142.00 Nov 13, 2020 @ 158.40 +11.55%
Sep 23, 2020 Bvs Kulothungan   137.95 Oct 16, 2020 @ 145.95 +5.80%
Aug 20, 2020 Syed Azeem Ahmed   127.60 Sep 11, 2020 @ 130.70 +2.43%
Aug 11, 2020 aju mapi map   90.80 Sep 04, 2020 @ 132.30 +45.70%
Jul 17, 2020 aju mapi map   61.80 Aug 07, 2020 @ 82.40 +33.33%
Jun 02, 2020 SuryaVamshi Tej   57.95 Jun 26, 2020 @ 70.70 +22.00%
May 07, 2020 ajay joshi   87.95 May 29, 2020 @ 53.85 -38.77%
May 06, 2020 mageswaran Mahi   83.80 May 29, 2020 @ 53.85 -35.74%
May 06, 2020 Jashanpreet Singh   83.80 May 29, 2020 @ 53.85 +35.74%
Apr 21, 2020 Sharad Patil   51.65 May 15, 2020 @ 79.00 +52.95%
Apr 11, 2020 Sharad Patil   38.70 Apr 12, 2020 @ 38.70 0.00%
Apr 08, 2020 Rishi Bothare   36.90 Apr 12, 2020 @ 38.70 +4.88%
Mar 25, 2020 Panna Lal   25.10 Apr 17, 2020 @ 46.90 +86.85%
Aug 06, 2019 rishabh soni   32.15 Aug 30, 2019 @ 31.35 -2.49%
Mar 08, 2019 Karan Ram   62.05 Mar 29, 2019 @ 54.60 -12.01%
Feb 13, 2019 Abid Sayyed   46.60 Mar 15, 2019 @ 65.00 +39.48%
Jan 23, 2019 SACHINN SINGH   70.30 Feb 23, 2019 @ 171.40 -143.81%
Jan 23, 2019 jugal chande   70.30 Feb 23, 2019 @ 171.40 -143.81%
Nov 02, 2018 Jai Sethia   82.30 Dec 02, 2018 @ 171.40 +108.26%
Oct 10, 2018 Pramod Kundar   68.50 Nov 06, 2018 @ 82.80 +20.88%
Aug 20, 2018 Puneet Mahajan   84.95 Aug 20, 2018 @ 84.95 0.00%
Mar 05, 2018 Saravana kumar   159.95 Apr 04, 2018 @ 171.75 -7.38%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MADR Comments

Write your thoughts about Mangalam Drugs and Organics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Praveen Nakod
Praveen Nakod Jun 29, 2020 12:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When will can we get earning report
Praveen Nakod
Praveen Nakod Jun 18, 2020 8:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At what price can we bye
Datta Nagari
Datta Nagari Jun 18, 2020 8:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
150
KEKIN patel
KEKIN patel May 07, 2020 1:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
still i think littel correction will come, but its good time to buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email